Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumors
- 29 August 2023
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (11) , 2717-2727
Abstract
Objective: To compare the risk of ovarian malignancy algorithm (ROMA) and Copenhagen Index (CPH‐I) in their ability to distinguish epithelial ovarian cancer (EOC) and malignant ovarian tumors (MLOT) from benign ovarian tumors (BeOT) in Japanese women.Methods: Patients with pathologically diagnosed ovarian tumors were included in this study. The study validated the diagnostic performance of ROMA and CPH‐I.Results: Among the 463 Japanese women included in this study, 312 had BeOT, 99 had EOC, and 52 had other MLOT. The receiver‐operator characteristic (ROC) area under the curve (AUCs) of ROMA (0.89) and CPH‐I (0.89) for distinguishing EOC from BeOT were significantly higher than that of CA125 (0.82) (CA 125 vs. ROMA; p = 0.002, vs. CPH‐I; p < 0.001). The ROC‐AUCs of ROMA (0.82) and CPH‐I (0.81) for distinguishing MLOT from BeOT were significantly higher than that of CA125 (0.75) (CA 125 vs. ROMA: p = 0.003, vs. CPH‐I: p < 0.001). The sensitivity (SN)/specificity (SP) of ROMA and CPH‐I for distinguishing EOC from BeOT at standard cut‐off points were 69%/90%, and 69%/90%, respectively, those for distinguishing MLOT from BeOT were 54%/90%, and 55%/90%, respectively.Conclusion: ROMA and CPH‐I performed comparably well and better than CA125 in distinguishing EOC from BeOT in Japanese women. ROMA and CHP‐I should be used with caution in practical situations, where all histological possibilities for must be considered, because the SNs of ROMA and CPH‐I were only 54% and 55%.Keywords
This publication has 14 references indexed in Scilit:
- Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis groupAmerican Journal of Obstetrics and Gynecology, 2016
- Comparing the Copenhagen Index (CPH-I) and Risk of Ovarian Malignancy Algorithm (ROMA): Two equivalent ways to differentiate malignant from benign ovarian tumors before surgery?Gynecologic Oncology, 2016
- A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian massGynecologic Oncology, 2015
- Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findingsJournal of Gynecologic Oncology, 2015
- Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese womenTumor Biology, 2014
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Centralisation of services for gynaecological cancers — A Cochrane systematic reviewGynecologic Oncology, 2012
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic massGynecologic Oncology, 2008
- Who should operate on patients with ovarian cancer? An evidence-based reviewGynecologic Oncology, 2005